Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy humour pharma

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more - 2 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 4 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 10 months ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 11 months ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - 11 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 11 months ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - 11 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 11 months ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - 12 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud - about 1 year ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - about 1 year ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - about 1 year ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - about 1 year ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - about 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - about 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - over 1 year ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Investigators Develop Training Tool to Improve Prescriber-Patient Communication About Biosimilars - about 1 month ago Condition Watch, August 2024: Dermatology - 5 months ago Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 10 months ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - about 1 month ago
4	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - 3 months ago
5	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Lawmakers Pan DEA's Leaked Plans for Telehealth - 3 months ago Medical Schools Push Back on 'March-In' Rights Plan to Lower Drug Prices - 12 months ago Medicine Is Not Just at a Crossroads, It's in a Crisis, AMA President Says - about 1 year ago Private Equity, For-Profit Interests Hurt Medicine, Conference Speakers Say - about 1 year ago
6	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 4 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	APL and CurifyLabs partner to support patients with 3D printing medicine technology - 4 months ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 5 months ago
9	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	Food As Medicine Can Change Patient Lives, But Establishing Models, Payment Pathways Is Critical - 5 months ago
10	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? - 7 months ago

Journalists covering medicine